康哲药业2025年营收重回增长,但一次性非经营事项致账面利润下滑,管理层:2025年开启长周期增长新起点

每日经济新闻
Mar 18

3月16日晚间,康哲药业发布2025年度业绩公告,并于次日上午召开线上业绩交流会,康哲药业高管团队出席了会议。  年报数据显示,2025年,康哲药业实现营业额82.12亿元,同比增长9.9%;剔除一次性非经营事项后的正常化净利润为17.8亿元,同比增长3.6%。公司拟派末期股息每股人民币0.14元,全年每股股息同比增长9.0%。  康哲药业在接受《每日经济新闻》记者采访时表示,自2022年起,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10